<DOC>
	<DOCNO>NCT00111631</DOCNO>
	<brief_summary>This study ass efficacy , safety tolerability DPP-IV Inhibitor patient type 2 diabetes receive stable dose metformin . The anticipated time study treatment 3-12 month target sample size 100-500 individual .</brief_summary>
	<brief_title>A Study DPP-IV Inhibitor Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>adult patient 1875 year age ; type 2 diabetes ; stable metformin therapy &gt; =3 month screen . woman pregnant , breastfeeding , use adequate contraceptive method ; type 1 diabetes ; antihyperglycemic medication metformin last 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>